FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
06-22-2017, 07:19 AM | #1 | |||
|
||||
Grand Magnate
|
Masitinib Phase 3 Trial Data Show Slowed Amyotrophic Lateral Sclerosis Progression, AB Science Says
ALS Progression Slowed by Masitinib, Phase 3 Clinical Study Data Show |
|||
Reply With Quote |
06-22-2017, 07:20 AM | #2 | |||
|
||||
Grand Magnate
|
AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS) at the European Network for the Cure of ALS (ENCALS) annual meeting
AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS) at the European Network for the Cure of ALS (ENCALS) annual meeting – MilTech |
|||
Reply With Quote |
06-22-2017, 07:21 AM | #3 | |||
|
||||
Grand Magnate
|
AB Science trumpets phase 3 ALS data, but investors seem unmoved
AB Science trumpets phase 3 ALS data, but investors seem unmoved | FierceBiotech |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
AB Science presents phase 3 data for masitinib in amyotrophic lateral sclerosis (ALS) | ALS News & Research | |||
Brainstorm Cell Therapeutics Set To Begin Phase 3 In Amyotrophic Lateral Sclerosis | ALS News & Research | |||
New Treatment for Amyotrophic Lateral Sclerosis Passes Phase III Trials | ALS News & Research | |||
Discovery offers hope of halting Amyotrophic Lateral Sclerosis progression | ALS News & Research |